Adults with neovascular age-related macular degeneration

Clinical trials for Adults with neovascular age-related macular degeneration explained in plain language.

Never miss a new study

Get alerted when new Adults with neovascular age-related macular degeneration trials appear

Sign up with your email to follow new studies for Adults with neovascular age-related macular degeneration, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 1

New eye drug aims to block two causes of vision loss at once

Disease control Not yet recruiting

This study tests an investigational drug called OCUL101 for people with wet age-related macular degeneration (AMD), a condition that causes blurry vision and can lead to blindness. OCUL101 targets two proteins involved in the disease to reduce abnormal blood vessel growth and inf…

Matched conditions: ADULTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

Phase 2/3 • Sponsor: Shenzhen Oculgen Biomedical Technology Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 12:06 UTC

Adults with neovascular age-related macular degeneration

Get alerted when new Adults with neovascular age-related macular degeneration trials appear

New eye drug aims to block two causes of vision loss at once